SREBF2 and Parkinson disease: In support of this study, our results further suggested that down-regulation of SREBP2 activity might be useful to reduce cholesterol level for preventing α-syn toxicity in PD brain since high level of cholesterol is tightly related to α-syn aggregation in PD (Bosco et al., 2006).